Carrier detection in ornithine transcarbamylase deficiency
Eric Haan, David M. Danks, Andrew Grimes, Nicholas J. Hoogenraad
Abstract
Eric Haan, David M. Danks, Andrew Grimes, Nicholas J. Hoogenraad
Abstract
We have studied six known heterozygotes for ornithine transcarbamylase (McKusick 31125; OTC) deficiency. All had abnormal results when tested by measurement of urine orotic acid after protein loading. Duodenal mucosa OTC assay detected fewer of the known heterozygotes but was a useful supplementary test. Urine orotic acid excretion after protein loading is influenced by age and results from women being tested must be compared with those from controls of appropriate age.
OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We have studied six known heterozygotes for ornithine transcarbamylase (McKusick 31125; OTC) deficiency. All had abnormal results when tested by measurement of urine orotic acid after protein loading. Duodenal mucosa OTC assay detected fewer of the known heterozygotes but was a useful supplementary test. Urine orotic acid excretion after protein loading is influenced by age and results from women being tested must be compared with those from controls of appropriate age.
Key concepts: Orotic acid, Ornithine transcarbamylase, Ornithine transcarbamylase deficiency, Heterozygote advantage, Ornithine Carbamoyltransferase, Urine, Excretion, Internal medicine